ESPIMOAT: Effectiveness of Spirometry as a Motivational Tool to Quit Smoking

Sponsor
Basque Health Service (Other)
Overall Status
Completed
CT.gov ID
NCT01821885
Collaborator
(none)
335
1
2
33
10.1

Study Details

Study Description

Brief Summary

The aim of the study is to asses the efficacy of the spirometry and a minimal smoking cessation counselling intervention to quit smoking after a year in patients older than 40 years, smokers of more than 10 packs-year and without a chronic obstructive pulmonary disease (COPD) diagnosis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Spirometry and a brief advice to quit smoking
  • Behavioral: Brief advice to quit smoking
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
335 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Spirometry and the Report of Spirometric Test Results by a Primary Care Physician on Smoking Cessation Rate in Adult Smokers: a Randomized Controlled Trial.
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Dec 1, 2013
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Spirometry and a brief advice to quit smoking

Intervention group: The intervention consists of completing a questionnaire and undergo spirometry with bronchodilator test by a trained nurse. Later, the patients receives a brief advice to quit smoking and a report of the spirometry results by their family doctor.

Behavioral: Spirometry and a brief advice to quit smoking
During a year, recruitment for active smoker patients was done by doctors in primary care medical offices. In the intervention group, after been randomized, one trained nurse completed the questionnaires and did the spirometry with bronchodilator test and set a date with its family doctor who did a minimal smoking cessation counselling intervention and informed the patients about the spirometry results according to established protocol.

Active Comparator: Brief advice to quit smoking

Control group: Patients in the control group complete a questionnaire by a nurse and then receive a brief advice to quit smoking by their family doctor.

Behavioral: Brief advice to quit smoking
During a year, recruitment for active smokers patients occurred through doctors in primary care medical offices. After be randomized, in de control group, a nurse complete the questionnaires. Below, patients go to the family doctor who will do a minimal smoking cessation counselling intervention.

Outcome Measures

Primary Outcome Measures

  1. The primary measure of results will be the differences in smoking cessation rates between intervention and control groups [12 months after been conducted the intervention]

    In all patients who report smoking withdrawal, smoking cessation will be confirmed by air carbon monoxide concentration.

Secondary Outcome Measures

  1. Reduce the number of cigarettes among those who continue smoking [12 months after been conducted the intervention]

    One secondary outcome will be to reduce the number of cigarettes. In all patients who continue smoking will be recorded the number of cigarettes smoked per day currently

  2. Increase smoking abstinence rates in patients with COPD [12 months after been conducted the intervention]

    Evaluate the differences in smoking cessation rates between patients with COPD and those without.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Active smokers over 40 years and more than 10 pack-years
Exclusion Criteria:
  • Previous diagnosis of respiratory disease (asthma, COPD, interstitial lung disease) that cause alteration of spirometric pattern.

  • Patients with limitations in performing spirometry

  • Age greater than 80 years

  • Institutionalized patients

  • Patients with a life expectancy less than 1 year

  • Spirometry in the past 2 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Basque health service Vitoria-Gasteiz Alava 45 Spain 1006

Sponsors and Collaborators

  • Basque Health Service

Investigators

  • Principal Investigator: Mª Isabel Irizar Aramburu, Osakidetza

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mº Isabel Irizar Aramburu, family doctor, Basque Health Service
ClinicalTrials.gov Identifier:
NCT01821885
Other Study ID Numbers:
  • 2011111013
  • KRONIK11/071 - EJGV 2011111013
First Posted:
Apr 1, 2013
Last Update Posted:
Jan 27, 2015
Last Verified:
Jan 1, 2015
Keywords provided by Mº Isabel Irizar Aramburu, family doctor, Basque Health Service

Study Results

No Results Posted as of Jan 27, 2015